Company / Depreciation & Amortization
AYTU BIOPHARMA, INC Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$8.3M
FY2024
5-year range
$8.3M / $10.1M
FY2020-FY2024
Trend
-6.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 9 years, ranging from $118,202 in FY2015 to $10M in FY2022.
Based on SEC 10-K filings.
$8M in FY2024 with a 3-year CAGR of -3.5%.
Improved from $10M to $8M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -3.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -3.5%, indicating a declining trend.
- In FY2024, depreciation & amortization decreased 6.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
- Lowest depreciation & amortization in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $8.3M | -6.2% |
| FY2023 | $8.8M | -13.1% |
| FY2022 | $10.1M | +10.3% |
| FY2021 | $9.2M | +61.0% |
| FY2020 | $5.7M | +120.5% |
| FY2018 | $2.6M | -40.6% |
| FY2017 | $4.4M | +398.9% |
| FY2016 | $874.8K | +640.1% |
| FY2015 | $118.2K | +102.6% |
As of FY2024 · SEC Form 10-K · Last checked Jun 21, 2026